Atyr Pharma Inc (ATYR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2000 | 09-2000 | 06-2000 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 430,650 | 689,780 | 175,780 |
| Marketable Securities | 0 | 24,890 | 98,060 |
| Receivables | 103,580 | 102,580 | 13,950 |
| Inventories | 91,660 | 101,930 | 8,220 |
| Other current assets | 45,850 | 38,800 | 12,950 |
| TOTAL | $671,740 | $957,980 | $308,960 |
| Non-Current Assets | |||
| Other Non-Current Assets | 1,525,940 | 1,613,010 | 11,620 |
| TOTAL | $1,525,940 | $1,613,010 | $11,620 |
| Total Assets | $2,369,210 | $2,735,080 | $346,430 |
| Liabilities | |||
| Current Liabilities | |||
| Short Term Debt | 840 | 820 | 740 |
| Accounts payable and accrued liabilities | 34,100 | 27,210 | 4,030 |
| Accrued Expenses | 69,830 | 82,080 | 10,240 |
| Other current liabilities | 0 | 1,790,640 | 0 |
| TOTAL | $153,020 | $2,066,800 | $15,440 |
| Non-Current Liabilities | |||
| Long Term Debt | 6,700 | 11,090 | 2,780 |
| Other Non-Current Liabilities | 199,130 | 177,350 | 172,500 |
| TOTAL | $437,760 | $462,230 | $175,280 |
| Total Liabilities | $590,810 | $2,529,040 | $190,720 |
| Shareholders' Equity | |||
| Common Shares | 510 | 240 | 230 |
| Retained earnings | -44,620 | 7,040 | 12,650 |
| Other shareholders' equity | 4,380 | -3,570 | -1,190 |
| TOTAL | $1,778,390 | $206,030 | $155,700 |
| Total Liabilities And Equity | $2,369,200 | $2,735,070 | $346,420 |